Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial (2010)
- Authors:
- Autor USP: MARIN NETO, JOSE ANTONIO - FMRP
- Unidade: FMRP
- Subjects: ULTRASSONOGRAFIA; DIABETES MELLITUS; ARTERIOSCLEROSE
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Circulation
- ISSN: 0009-7322
- Volume/Número/Paginação/Ano: v. 121, n. 10, p. 1176-1187, 2010
-
ABNT
GERSTEIN, Hertzel C. et al. Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial. Circulation, v. 121, n. 10, p. 1176-1187, 2010Tradução . . Acesso em: 21 maio 2024. -
APA
Gerstein, H. C., Ratner, R. E., Cannon, C. P., Serruys, P. W., García-García, H. M., Es, G. -A. van, et al. (2010). Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial. Circulation, 121( 10), 1176-1187. -
NLM
Gerstein HC, Ratner RE, Cannon CP, Serruys PW, García-García HM, Es G-A van, Kolatkar NS, Kravitz BG, Miller DM, Huang C, Fitzgerald PJ, Nesto RW, Marin Neto JA. Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial. Circulation. 2010 ; 121( 10): 1176-1187.[citado 2024 maio 21 ] -
Vancouver
Gerstein HC, Ratner RE, Cannon CP, Serruys PW, García-García HM, Es G-A van, Kolatkar NS, Kravitz BG, Miller DM, Huang C, Fitzgerald PJ, Nesto RW, Marin Neto JA. Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial. Circulation. 2010 ; 121( 10): 1176-1187.[citado 2024 maio 21 ] - Determinacao da lesao miocardica isquemica por 99m-tecnecio-pirofosfato e azul de evans: efeito da dexametasona
- Clinical significance of reduced regional glucose uptake with normal blood flow in patients with chronic coronary artery disease
- Deteccao de viabilidade miocardica: meta atual da avaliacao em cardiopatas isquemicos com disfuncao ventricular
- Significado clinico da redistribuicao reversa de talio-201 na cardiopatia isquemica cronica
- Myocardial viability: comparison of thallium reinjection rest-stress sestamibi and positron emission tomography
- Métodos de avaliação da circulação pulmonar
- Infarto "Necrosette" versus infarto do miocárdio sem supra-desnivelamento ST (IAMSS) tradicionamente definido e evolução hospitalar: resultados do GRACE(Global Registry of Acute Myocardial Events)
- Segurança da combinação de heparina de baixo peso molecular com inibidores da glicoproteína IIB/IIIA: resultados do registro GRACE
- Agradeço pela ocasião de, como editor convidado ...[Editorial]
- Prevalence of autonomic dysfunction and echocardiographic abnormalities in different eletrocardiographic stages of asymptomatic T. cruzi infection: the CHICAMOCHA pilot study
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
